Clinical trial
Open, Randomized, Active Comparator-controlled, Multi-Center Study to Evaluate Safety and Efficacy of IBsolvMIR® in Islet Transplantation
NCT03867851 is registered in ClinicalTrials.gov with TikoMed AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open, Randomized, Active Comparator-controlled, Multi-Center Study to Evaluate Safety and Efficacy of IBsolvMIR® in Islet Transplantation
- Lead sponsor
- TikoMed AB
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- February 8, 2021
- Completion date
- May 13, 2024
- Enrollment
- 7 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.